A platform for anti-biofilm assays combining viability, biomass and matrix quantifications in susceptibility assessments of antimicrobials against Staphylococcus aureus biofilms
Skogman, Malena (2012-11-09)
Skogman, Malena
Åbo Akademi - Åbo Akademi University
09.11.2012
Julkaisu on tekijänoikeussäännösten alainen. Teosta voi lukea ja tulostaa henkilökohtaista käyttöä varten. Käyttö kaupallisiin tarkoituksiin on kielletty.
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi-fe201311117333
https://urn.fi/URN:NBN:fi-fe201311117333
Tiivistelmä
Bacteria can exist as planktonic, the lifestyle in which single cells exist in suspension, and
as biofilms, which are surface-attached bacterial communities embedded in a selfproduced
matrix. Most of the antibiotics and the methods for antimicrobial work have
been developed for planktonic bacteria. However, the majority of the bacteria in natural
habitats live as biofilms. Biofilms develop dauntingly fast high resistance towards
conventional antibacterial treatments and thus, there is a great need to meet the
demands of effective anti-biofilm therapy.
In this thesis project it was attempted to fill the void of anti-biofilm screening methods by
developing a platform of assays that evaluate the effect that screened compounds have on
the total biomass, viability and the extracellular polysaccharide (EPS) layer of the
biofilms. Additionally, a new method for studying biofilms and their interactions with
compounds in a continuous flow system was developed using capillary
electrochromatography (CEC). The screening platform was utilized with a screening
campaign using a small library of cinchona alkaloids.
The assays were optimized to be statistically robust enough for screening. The first assay,
based on crystal violet staining, measures total biofilm biomass, and it was automated
using a liquid handling workstation to decrease the manual workload and signal
variation. The second assay, based on resazurin staining, measures viability of the biofilm,
and it was thoroughly optimized for the strain used, but was then a very simple and fast
method to be used for primary screening. The fluorescent resazurin probe is not toxic to
the biofilms. In fact, it was also shown in this project that staining the biofilms with
resazurin prior to staining with crystal violet had no effect on the latter and they can be
used in sequence on the same screening plate. This sequential addition step was indeed a
major improvement on the use of reagents and consumables and also shortened the work
time. As a third assay in the platform a wheat germ agglutinin based assay was added to
evaluate the effect a compound has on the EPS layer. Using this assay it was found that
even if compounds might have clear effect on both biomass and viability, the EPS layer
can be left untouched or even be increased. This is a clear implication of the importance
of using several assays to be able to find “true hits” in a screening setting.
In the pilot study of screening for antimicrobial and anti-biofilm effects using a cinchona
alkaloid library, one compound was found to have antimicrobial effect against planktonic
bacteria and prevent biofilm formation at low micromolar concentration. To eradicate
biofilms, a higher concentration was needed. It was also shown that the chemical space
occupied by the active compound was slightly different than the rest of the cinchona
alkaloids as well as the rest of the compounds used for validatory screening during the
optimization processes of the separate assays.
as biofilms, which are surface-attached bacterial communities embedded in a selfproduced
matrix. Most of the antibiotics and the methods for antimicrobial work have
been developed for planktonic bacteria. However, the majority of the bacteria in natural
habitats live as biofilms. Biofilms develop dauntingly fast high resistance towards
conventional antibacterial treatments and thus, there is a great need to meet the
demands of effective anti-biofilm therapy.
In this thesis project it was attempted to fill the void of anti-biofilm screening methods by
developing a platform of assays that evaluate the effect that screened compounds have on
the total biomass, viability and the extracellular polysaccharide (EPS) layer of the
biofilms. Additionally, a new method for studying biofilms and their interactions with
compounds in a continuous flow system was developed using capillary
electrochromatography (CEC). The screening platform was utilized with a screening
campaign using a small library of cinchona alkaloids.
The assays were optimized to be statistically robust enough for screening. The first assay,
based on crystal violet staining, measures total biofilm biomass, and it was automated
using a liquid handling workstation to decrease the manual workload and signal
variation. The second assay, based on resazurin staining, measures viability of the biofilm,
and it was thoroughly optimized for the strain used, but was then a very simple and fast
method to be used for primary screening. The fluorescent resazurin probe is not toxic to
the biofilms. In fact, it was also shown in this project that staining the biofilms with
resazurin prior to staining with crystal violet had no effect on the latter and they can be
used in sequence on the same screening plate. This sequential addition step was indeed a
major improvement on the use of reagents and consumables and also shortened the work
time. As a third assay in the platform a wheat germ agglutinin based assay was added to
evaluate the effect a compound has on the EPS layer. Using this assay it was found that
even if compounds might have clear effect on both biomass and viability, the EPS layer
can be left untouched or even be increased. This is a clear implication of the importance
of using several assays to be able to find “true hits” in a screening setting.
In the pilot study of screening for antimicrobial and anti-biofilm effects using a cinchona
alkaloid library, one compound was found to have antimicrobial effect against planktonic
bacteria and prevent biofilm formation at low micromolar concentration. To eradicate
biofilms, a higher concentration was needed. It was also shown that the chemical space
occupied by the active compound was slightly different than the rest of the cinchona
alkaloids as well as the rest of the compounds used for validatory screening during the
optimization processes of the separate assays.
Kokoelmat
- 317 Farmasia [14]